FULGENT GENETICS, INC. Finance Lease, Liability, Current
FULGENT GENETICS, INC. (FLGT) had Finance Lease, Liability, Current of $181.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-07-30
- 2026-06-30: Finance Lease, Liability, Current $181.00K.
- 2026-03-31: Finance Lease, Liability, Current $271.00K.
- 2025-12-31: Finance Lease, Liability, Current $360.00K.
- 2025-09-30: Finance Lease, Liability, Current $357.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2026-06-30 | $181.00K 10-Q · filed 2026-07-30 |
| 2026-03-31 | $271.00K 10-Q · filed 2026-05-01 |
| 2025-12-31 | $360.00K 10-Q · filed 2026-07-30 |
| 2025-09-30 | $357.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $354.00K 10-Q · filed 2025-08-01 |
| 2025-03-31 | $351.00K 10-Q · filed 2025-05-02 |
| 2024-12-31 | $398.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $449.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $492.00K 10-Q · filed 2024-08-02 |
| 2024-03-31 | $543.00K 10-Q · filed 2024-05-03 |
| 2023-12-31 | $544.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $537.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $535.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $954.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $943.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $927.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $741.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $335.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $332.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $16.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |